{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:15:17Z","timestamp":1782875717145,"version":"3.54.5"},"reference-count":43,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: To report on prophylactic therapy for hyperfibrinolysis with tranexamic acid (TXA) during expectant management (EM) in the placenta accreta spectrum (PAS). Methods: This is a monocentric retrospective study of women with PAS presenting at our hospital between 2005 and 2021. All data were retrospectively collected through the departmental database. Results: 35 patients with PAS were included. EM was planned in 25 patients prior to delivery. Complete absorption of the retained placenta was seen in two patients (8%). Curettage was performed in 14 patients (56%). A hysterectomy (HE) was needed in seven (28%) patients; 18 patients (72%) underwent uterus-preserving treatment without severe complications. The mean duration of EM was 107 days. The mean day of onset of hyperfibrinolysis and beginning of TXA treatment was day 45. The mean nadir of fibrinogen level before TXA was 242.4 mg\/dL, with a mean drop of 29.7% in fibrinogen level. Conclusions: Our data support EM as a safe treatment option in PAS. Hyperfibrinolysis can be a cause of hemorrhage during EM and can be treated with TXA. To our knowledge, this is the first cohort of patients with EM of PAS in whom coagulation monitoring and use of TXA have been shown to successfully treat hyperfibrinolysis.<\/jats:p>","DOI":"10.3390\/jcm13010135","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T02:58:12Z","timestamp":1703645892000},"page":"135","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Placenta Accreta Spectrum Prophylactic Therapy for Hyperfibrinolysis with Tranexamic Acid"],"prefix":"10.3390","volume":"13","author":[{"given":"Tiyasha Hosne","family":"Ayub","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-7097","authenticated-orcid":false,"given":"Brigitte","family":"Strizek","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Poetzsch","sequence":"additional","affiliation":[{"name":"Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2201-1494","authenticated-orcid":false,"given":"Philipp","family":"Kosian","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-4669","authenticated-orcid":false,"given":"Ulrich","family":"Gembruch","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waltraut M.","family":"Merz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/j.jacr.2020.01.031","article-title":"ACR Appropriateness Criteria\u00ae Placenta Accreta Spectrum Disorder","volume":"17","author":"Poder","year":"2020","journal-title":"J. Am. Coll. Radiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijgo.12410","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel FIGO Consensus Guidelines on Placenta Accreta Spectrum Disorders: Conservative Management","volume":"140","author":"Sentilhes","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ogc.2015.01.014","article-title":"Placenta Accreta Spectrum","volume":"42","author":"Silver","year":"2015","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel FIGO Consensus Guidelines on Placenta Accreta Spectrum Disorders: Epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta Accreta Spectrum: Pathophysiology and Evidence-Based Anatomy for Prenatal Ultrasound Imaging","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.placenta.2011.11.010","article-title":"Placenta Accreta: Pathogenesis of a 20th Century Iatrogenic Uterine Disease","volume":"33","author":"Jauniaux","year":"2012","journal-title":"Placenta"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/PGP.0000000000000250","article-title":"Histopathology of Placenta Creta: Chorionic Villi Intrusion into Myometrial Vascular Spaces and Extravillous Trophoblast Proliferation Are Frequent and Specific Findings with Implications for Diagnosis and Pathogenesis","volume":"35","author":"Djordjevic","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_8","first-page":"E1","article-title":"Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a","volume":"126","author":"Jauniaux","year":"2019","journal-title":"BJOG"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.ajog.2012.12.037","article-title":"Placenta Accreta: Risk Factors, Perinatal Outcomes, and Consequences for Subsequent Births","volume":"208","author":"Eshkoli","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3109\/14767058.2011.553695","article-title":"The Effect of Cesarean Delivery Rates on the Future Incidence of Placenta Previa, Placenta Accreta, and Maternal Mortality","volume":"24","author":"Solheim","year":"2011","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-0412.2012.01520.x","article-title":"Reoccurrence of Retained Placenta at Vaginal Delivery: An Observational Study","volume":"92","author":"Nikolajsen","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.09.042","article-title":"Placenta Accreta Spectrum","volume":"219","author":"Cahill","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(18)31930-5","article-title":"Short-Term and Long-Term Effects of Caesarean Section on the Health of Women and Children","volume":"392","author":"Sandall","year":"2018","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.AOG.0000219750.79480.84","article-title":"Maternal Morbidity Associated With Multiple Repeat Cesarean Deliveries","volume":"107","author":"Silver","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajog.2015.04.034","article-title":"Conservative Management of Morbidly Adherent Placenta: Expert Review","volume":"213","author":"Fox","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajog.2020.01.044","article-title":"Minimizing Surgical Blood Loss at Cesarean Hysterectomy for Placenta Previa with Evidence of Placenta Increta or Placenta Percreta: The State of Play in 2020","volume":"223","author":"Kingdom","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijgo.12409","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel FIGO Consensus Guidelines on Placenta Accreta Spectrum Disorders: Nonconservative Surgical Management","volume":"140","author":"Allen","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/aogs.12075","article-title":"Surgical Management of Placenta Accreta: A 10-year Experience","volume":"92","author":"Tan","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/aogs.12222","article-title":"Management of Placenta Accreta","volume":"92","author":"Sentilhes","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1471-0528.12405","article-title":"The Management and Outcomes of Placenta Accreta, Increta, and Percreta in the UK : A Population-based Descriptive Study","volume":"121","author":"Fitzpatrick","year":"2014","journal-title":"BJOG"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.AOG.0000136086.78099.0f","article-title":"Conservative Versus Extirpative Management in Cases of Placenta Accreta","volume":"104","author":"Kayem","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.ogx.0000271133.27011.05","article-title":"Conservative Management of Abnormally Invasive Placentation","volume":"62","author":"Timmermans","year":"2007","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/AOG.0b013e3181d066d4","article-title":"Maternal Outcome After Conservative Treatment of Placenta Accreta","volume":"115","author":"Sentilhes","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/humrep\/deq239","article-title":"Fertility and Pregnancy Outcomes Following Conservative Treatment for Placenta Accreta","volume":"25","author":"Sentilhes","year":"2010","journal-title":"Hum. Reprod."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/aogs.12295","article-title":"Management of Placenta Percreta: A Review of Published Cases","volume":"93","author":"Clausen","year":"2014","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/ajo.12149","article-title":"Maternal Outcome after Conservative Management of Placenta Percreta at Caesarean Section: A Report of Three Cases and a Review of the Literature","volume":"54","author":"Pather","year":"2014","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/aogs.12078","article-title":"The PACCRETA group PACCRETA: Clinical Situations at High Risk of Placenta ACCRETA\/Percreta: Impact of Diagnostic Methods and Management on Maternal Morbidity","volume":"92","author":"Kayem","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejogrb.2006.07.050","article-title":"Management of Placenta Accreta: Morbidity and Outcome","volume":"133","author":"Bretelle","year":"2007","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Matsuzaki, S., Yoshino, K., Endo, M., Tomimatsu, T., Takiuchi, T., Mimura, K., Kumasawa, K., Ueda, Y., and Kimura, T. (2017). Successful Anticoagulant Therapy for Disseminated Intravascular Coagulation during Conservative Management of Placenta Percreta: A Case Report and Literature Review. BMC Pregnancy Childbirth, 17.","DOI":"10.1186\/s12884-017-1634-8"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00404-020-05721-0","article-title":"Conservative Management of Abnormally Invasive Placenta Complicated by Local Hyperfibrinolysis and Beginning Disseminated Intravascular Coagulation","volume":"303","author":"Biele","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/AOG.0000000000000915","article-title":"Tranexamic Acid for Hyperfibrinolytic Hemorrhage During Conservative Management of Placenta Percreta","volume":"126","author":"Gembruch","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated Intravascular Coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic Acid: A Review of Its Use in the Treatment of Hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00404-019-05175-z","article-title":"Self-Reported Physical, Mental, and Reproductive Sequelae after Treatment of Abnormally Invasive Placenta: A Single-Center Observational Study","volume":"300","author":"Welz","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-2008-1027701","article-title":"Diagnosis, Treatment and Application of Color Doppler in Conservative Management of Abnormally Adherent Placenta","volume":"30","author":"Merz","year":"2008","journal-title":"Ultraschall Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/uog.26155","article-title":"Delphi consensus expert panel Modified Delphi Study of Ultrasound Signs Associated with Placenta Accreta Spectrum","volume":"61","author":"Jauniaux","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/uog.1926","article-title":"Antenatal Diagnosis of Placenta Accreta: A Review: Antenatal Diagnosis of Placenta Accreta","volume":"26","author":"Comstock","year":"2005","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/uog.14952","article-title":"Proposal for Standardized Ultrasound Descriptors of Abnormally Invasive Placenta (AIP)","volume":"47","author":"Collins","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/jmf.16.6.355.356","article-title":"Transverse Fundal Uterine Incision in a Patient with Placenta Increta","volume":"16","author":"Shukunami","year":"2004","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00404-011-2204-3","article-title":"Measures for Peripartum Hysterectomy for Placenta Previa Accreta: Avoiding Uterotonic Agents and \u201cDouble Distal Edge Pickup\u201d Mass Ligation","volume":"285","author":"Matsubara","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00404-021-06384-1","article-title":"Trends, Characteristics, and Outcomes of Conservative Management for Placenta Percreta","volume":"306","author":"Youssefzadeh","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/aogs.14096","article-title":"A Multicenter Observational Survey of Management Strategies in 442 Pregnancies with Suspected Placenta Accreta Spectrum","volume":"100","author":"Stefanovic","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/AOG.0000000000000960","article-title":"Disseminated Intravascular Coagulation Complicating the Conservative Management of Placenta Percreta","volume":"126","author":"Judy","year":"2015","journal-title":"Obstet. Gynecol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/1\/135\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:42:13Z","timestamp":1760132533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/1\/135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["jcm13010135"],"URL":"https:\/\/doi.org\/10.3390\/jcm13010135","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]}}}